Olux and Swallowing difficulty - a phase IV clinical study of FDA data

Summary:

Swallowing difficulty is reported as a side effect among people who take Olux (clobetasol propionate), especially for people who are female, 60+ old, also take Cellcept, and have Psoriatic arthropathy.

The phase IV clinical study analyzes which people have Swallowing difficulty when taking Olux. It is created by eHealthMe based on reports of 602 people who have side effects when taking Olux from the FDA, and is updated regularly.

What is Olux?

Olux has active ingredients of clobetasol propionate. eHealthMe is studying from 614 Olux users. Check the latest studies of Olux.

What is Swallowing difficulty?

Swallowing difficulty is found to be associated with 2,400 drugs and 3,353 conditions by eHealthMe. Check the latest studies of Swallowing difficulty.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 26, 2026

602 people reported to have side effects when taking Olux.
Among them, 12 people (1.99%) have Swallowing difficulty.

Among these 12 people:

What is the gender of people who have Swallowing difficulty when taking Olux? *

female: 100 %
male: 0.0 %

What is the age of people who have Swallowing difficulty when taking Olux? *

What are other drugs people take besides Olux? *

What are other side effects people have besides Swallowing difficulty? *

Fatigue (feeling of tiredness): 6 people, 50.00%
Neurodegenerative Disorder (progressive loss of structure or function of neurons and death of neuron): 6 people, 50.00%
Speech Disorder: 6 people, 50.00%
Rickets (softening of bones): 4 people, 33.33%
Photosensitivity Reaction: 4 people, 33.33%
Polyarthritis (arthritis which involves 5 or more joints simultaneously): 4 people, 33.33%
Hot Flush (sudden feelings of heat): 4 people, 33.33%
Hormone Level Abnormal: 4 people, 33.33%
Musculoskeletal Discomfort (discomfort in the body's muscles, joints, tendons, ligaments and nerves): 4 people, 33.33%
Drug Ineffective: 4 people, 33.33%

What are the existing conditions these people have? *

Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 4 people, 33.33%
Immunodeficiency Disorders: 3 people, 25.00%
Sleep Disorder: 2 people, 16.67%
Pain: 2 people, 16.67%
Conjunctivitis (pink eye): 2 people, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take Olux and have Swallowing difficulty?

- Check whether Swallowing difficulty is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Olux:

Olux (614 reports)

Browse all side effects of Olux:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Swallowing difficulty:

Swallowing difficulty (2,400 drugs)

Browse all the conditions that are associated with Swallowing difficulty:

Swallowing difficulty (3,353 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on clobetasol propionate (the active ingredients of Olux) and Olux (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.